This product claims to offer a painless, long-lasting alternative to semaglutide injections, delivering the powerful GLP-1 hormone through an innovative microneedle patch technology
Cash-pay costs for GLP-1 medications can be high without coverage, and coverage varies widely by plan
In Eli Lilly's Phase 2 clinical trial (published in the New England Journal of Medicine, 2023), 338 adults with obesity or overweight (without diabetes) were treated with retatrutide for 48 weeks
Assess outcomes using DXA or MRI, plus biomarkers like HbA1c, insulin, and CRP
The FDA approval is only for people with obesity, but it could help those with sleep apnea get Medicare coverage, which doesnt cover drugs just for weight loss, according to a report
Smoothies are a simple way to incorporate several nutrient-dense ingredients, ultimately boosting your health from the inside out